For instance, in triple damaging breast cancer (TNBC),twenty five and in hepatocellular carcinoma,26 DNA methylation profiles have assisted for the identification of distinct subgroups with clinical relevance. Epigenetic strategies have also aided to the development of prognostic assessments to assess the sensitivity of cancer cells to distinct drugs.27 Complete https://directivepublications.org/world-journal-of-clinical-cancer-research/